ProfileGDS4132 / 211500_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 86% 92% 87% 87% 87% 89% 90% 90% 86% 83% 86% 80% 82% 91% 80% 89% 90% 83% 81% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101332.23386
GSM201543Muscle PCOS pioglitazone 121433.76392
GSM201544Muscle PCOS pioglitazone 161395.14187
GSM201545Muscle PCOS pioglitazone 201397.37787
GSM201829Muscle PCOS pioglitazone 231371.18987
GSM201830Muscle PCOS pioglitazon 251400.47789
GSM201831Muscle PCOS pioglitazone 271425.97790
GSM201832Muscle PCOS pioglitazone 31424.26290
GSM201833Muscle PCOS pioglitazone 41339.4586
GSM201834Muscle PCOS pioglitazone 81313.32783
GSM201835Muscle PCOS after pioglitazone 102366.10686
GSM201836Muscle PCOS after pioglitazone 122275.42980
GSM201837Muscle PCOS after pioglitazone 162283.1882
GSM201838Muscle PCOS after pioglitazone 202522.52391
GSM201839Muscle PCOS after pioglitazone 232281.40280
GSM201840Muscle PCOS after pioglitazone 252454.63389
GSM201841Muscle PCOS after pioglitazone 272431.01490
GSM201842Muscle PCOS after pioglitazone 32285.34783
GSM201843Muscle PCOS after pioglitazone 42289.96281
GSM201844Muscle PCOS after pioglitazone 82346.99785